VC  Ascent Biomedical Ventures

http://www.abvlp.com





     Office Locations:

142 West 57th Street, Suite 4A
New York, NY 10019
Phone: 212-303-1680
Fax: 212-752-3633

 

Stages:

  • Early
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Ascent Biomedical Ventures (ABV) is a venture capital firm investing in seed and early-stage biomedical technology companies developing medical devices, biopharmaceuticals, healthcare services, and information technology. ABV's principals and advisors work closely with entrepreneurs to manage the risks associated with deploying capital in startup companies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Avi Kometz M.D. Partner
    Geoffrey W. Smith Managing Partner
    Jeffrey M. Sauerhoff Partner & CFO
    Jon Edelson M.D. Venture Partner
    Lawrence Atinsky Partner & General Counsel

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      12/16/2020


      Neurogene


      NY


      $115,000,000


      Series B


     

    Portfolio companies include:


      Coferon
        web link


      Neurogene
        web link


      Xlumena
        web link


     

    Recent News:


      There is no recent news for Ascent Biomedical Ventures.